Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cu-medicine-study-shows-modulation-of-gut-microbiota-helps-enhance-safety-and-efficacy-of-covid-19-vaccine
https://www.med.cuhk.edu.hk/press-releases/cu-medicine-study-shows-modulation-of-gut-microbiota-helps-enhance-safety-and-efficacy-of-covid-19-vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

The gut microbiome controls our immunity and protects us from invasion from pathogens. Studies have shown that it also plays a vital role in immune response after vaccination. Preliminary study in the laboratory using blood samples from individuals who have received COVID-19 vaccine showed that addition of a beneficial bacteria consortia developed by The Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) is effective in reducing inflammatory cytokines and enhancing antibody level. The research team is now launching clinical trials to investigate the impact of modulation of gut microbiota in reducing vaccine-related adverse reactions and improving efficacy of COVID-19 vaccine.

 

Preliminary study in the laboratory using blood samples from individuals who have received CVOVID-19 vaccine showed that addition of a beneficial bacteria consortia developed by CU Medicine is effective in reducing inflammatory cytokines and enhancing antibody level.    (From left): Dr. Joyce MAK, Assistant Professor of the Department of Medicine and Therapeutics; Professor Francis CHAN, Dean of Medicine and Director of the Centre for Gut Microbiota Research; and Professor Siew NG, Associate Director of the Centre for Gut Microbiota Research; at CU Medicine.

Preliminary study in the laboratory using blood samples from individuals who have received CVOVID-19 vaccine showed that addition of a beneficial bacteria consortia developed by CU Medicine is effective in reducing inflammatory cytokines and enhancing antibody level.

 

(From left): Dr. Joyce MAK, Assistant Professor of the Department of Medicine and Therapeutics; Professor Francis CHAN, Dean of Medicine and Director of the Centre for Gut Microbiota Research; and Professor Siew NG, Associate Director of the Centre for Gut Microbiota Research; at CU Medicine.

 

Gut microbiome Plays a Vital Role in Immune Response from Vaccination

 

Vaccine triggers the immune system to develop antibodies and memory cells to protect against future infections.  An unhealthy gut microbiome can hinder antibody production or lead to inflammatory cytokine storm, increasing the risk of adverse reactions. Earlier studies from CU Medicine have shown a link between altered gut microbiome and COVID-19 severity.  More patients who received a novel microbiome immunity formula achieved complete symptom resolution and developed neutralising antibody than those who did not. Research from the Faculty also reported that almost 40% of people in Hong Kong had significant gut dysbiosis especially the elderly and patients with diabetes, obesity or chronic diseases.

 

Improving Gut Microbiome to Enhance Safety and Efficacy of Vaccination

 

To support the hypothesis that the gut microbiome can impact vaccine response and safety, CU Medicine conducted a laboratory investigation. Researchers collected blood samples from ten subjects who recently received COVID-19 vaccination, whereby four of them had been taking the microbiome immunity formula developed by CU Medicine for up to two months prior to vaccination.  Our preliminary findings showed that subjects who had been taking the microbiome immunity formula showed up to 80% lower concentration of inflammatory cytokine and a 1.5-fold higher proportion of B cell, a blood cell that produces antibodies, in their blood compared with a control group.

 

Prof. Siew NG states that the early laboratory results suggest the microbiome immunity formula developed by CU Medicine can suppress inflammatory response associated with unwanted adverse events receiving COVID-19 vaccine.

Prof. Siew NG states that the early laboratory results suggest the microbiome immunity formula developed by CU Medicine can suppress inflammatory response associated with unwanted adverse events receiving COVID-19 vaccine.

Professor Siew Chien NG, Associate Director of the Centre for Gut Microbiota Research at CU Medicine, explained, “Our previous study showed that altered gut microbiome is linked to increased severity and persistent symptoms of COVID-19. Imbalanced gut microbiota is associated with systemic inflammation and blunted immune response to vaccination. These early laboratory results are encouraging and suggest that the microbiome immunity formula can suppress inflammatory response associated with unwanted adverse events after vaccination.” 

 

Large-scale Study to Investigate How Gut Microbiome Affects Vaccine Safety and Efficacy

 

Dr. Joyce MAK (left) hopes the clinical study on 500 vaccinated individuals will help enhance the safety and efficacy of COVID-19 vaccines.

Dr. Joyce MAK (left) hopes the clinical study on 500 vaccinated individuals will help enhance the safety and efficacy of COVID-19 vaccines. 

Based on these preliminary findings, CU Medicine is now launching clinical trials to recruit 500 subjects with type 2 diabetes mellitus and aged 65 or above, to investigate the effect of the microbiome immunity formula on COVID-19 vaccine response and safety.

 

It will be a randomised controlled study that includes participants randomised to microbiome immunity formula or placebo.

 

Dr. Joyce Wing Yan MAK, Assistant Professor of the Department of Medicine and Therapeutics at CU Medicine, said, “There is an urgent need to explore in what ways and how our gut microbiome affect vaccine response and adverse reactions.  We hope this clinical study will help enhance the safety of vaccination.”

 

Prof. Francis CHAN suggests that while society awaits more safety data on existing COVID-19 vaccines or the development of new vaccines, it is important for people to improve their gut microbiota to optimise the safety and efficacy of COVID-19 vaccines, which is especially crucial for the elderly, patients with obesity, diabetes or other chronic diseases.

Prof. Francis CHAN suggests that while society awaits more safety data on existing COVID-19 vaccines or the development of new vaccines, it is important for people to improve their gut microbiota to optimise the safety and efficacy of COVID-19 vaccines, which is especially crucial for the elderly, patients with obesity, diabetes or other chronic diseases.

Professor Francis KL CHAN, Dean of Medicine and Director of the Centre for Gut Microbiota Research at CUHK, concluded, “Our immune system is a ‘double-edged sword’. Vaccines can stimulate our immune system to induce antibody formation to protect us, but a lack of good bacteria can tip the balance to overwhelm our immune response leading to unwanted adverse effects. As we await more safety data on existing vaccines or the development of new vaccines, it is important for people to improve their gut microbiota to optimize the safety and efficacy of COVID-19 vaccines, which is especially crucial for the elderly, patients with obesity, diabetes or other chronic diseases.”

 

More Press Releases

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
CU Medicine Study Suggests Toddlers are at High Risk of Being  “Silent Spreaders of SARS-CoV2 Infection”

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”

Research
CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

Research
CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

Research
CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

Clinical service
CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

Research
CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

Research
CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

Research
CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

International collaboration
CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

Research
CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

Research
CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

Research
Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Research
CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

Research
CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19,  and Possible Mechanisms

CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19, and Possible Mechanisms

Research
CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

Research
CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

Research
CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

Research
Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Awards and honors
CUHK Establishes Hong Kong Hub of Paediatric Excellence (HK HOPE) Multidisciplinary Efforts Across the Globe to Advance Children’s Health and Well-being

CUHK Establishes Hong Kong Hub of Paediatric Excellence (HK HOPE) Multidisciplinary Efforts Across the Globe to Advance Children’s Health and Well-being

Health Campaign
Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Awards and honors
CUHK Pioneers in Introducing Museum-Based Observational Skills into Medical Education

CUHK Pioneers in Introducing Museum-Based Observational Skills into Medical Education

Education
CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

Research
CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

Research
CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

Research
Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Research
CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.